Neurocrine Bio. (NBIX) Sosei Deal Offers an Interesting Pipeline Opportunity - SVB Leerink

November 23, 2021 7:22 AM EST Send to a Friend
SVB Leerink analyst Marc Goodman reiterated a Market Perform rating and $100.00 price target on Neurocrine Bio. (NASDAQ: NBIX) finding ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login